Depression, anxiety, and stress during the sanitary emergency of COVID-19 in southeastern México

Conteúdo do artigo principal

Abel Emigdio-Vargas
Alfonso Dávalos-Martínez
Elia Barrera-Rodríguez
Juan Antonio Arreguín-Cano
Martha Herlinda Teliz-Sánchez
Nubia Oliday Blanco-García

Resumo

Aim: Evaluate the level of depression, anxiety, and stress; and identify the factors associated with these psychological responses during the third phase of the COVID-19 health emergency in a sample of Mexican population. Methods: An online cross-sectional survey was conducted. We performed bivariate and multivariate analyses to identify factors associated with depression, anxiety, and stress. Results: We included 997 individuals with a mean age of 35.3 ± 12.9 years; 18.9% of the participants presented symptoms of depression, 21.7% symptoms of anxiety and 14.1% symptoms of stress. Respondents were more likely to present depression if they were < 40 years old (OR 1.73), not having a religion (OR 1.71), if they were currently unemployed (OR 1.54). Factors associated with anxiety were age < 40 years old (OR 1.73) and having recent contact with suspected or diagnosed patients with COVID-19 (OR 1.54). Self-perception of insufficient knowledge about COVID-19 disease was associated with stress (OR 1.55). Declaring not feeling safe of COVID-19 infection was associated with depression (OR 2.03), anxiety (OR 1.90), and stress (OR 1.75). Conclusions: The damage to mental health caused by the COVID-19 pandemic is evident; health personnel must pay attention to their psychological state and well-being to take appropriate measures.

Detalhes do artigo

Seção
Artículos de Investigación
Biografia do Autor

Abel Emigdio-Vargas, Unidad de Innovación Clínica y Epidemiológica del Estado de Guerrero, Secretaría de Salud Guerrero, Acapulco, México.

Investigador en Ciencias Sociales

Alfonso Dávalos-Martínez, Unidad de Innovación Clínica y Epidemiológica del Estado de Guerrero, Secretaría de Salud Guerrero, Acapulco, México.

Investigador en Psicología Clínica

Elia Barrera-Rodríguez, Unidad de Innovación Clínica y Epidemiológica del Estado de Guerrero, Secretaría de Salud Guerrero, Acapulco, México.

Investigadora Clínica y Bioestadística

Juan Antonio Arreguín-Cano, Secretaría de Salud Guerrero

Investigador en Ciencias Médicas

Martha Herlinda Teliz-Sánchez, Secretaría de Salud Guerrero

Jefa del departamento de Investigación en Salud, Oficinas Centrales, Secretaría de Salud Guerrero, Chilpancingo de los Bravo, México. 

Nubia Oliday Blanco-García, Secretaría de Salud Guerrero

Encargada de la Dirección de la Unidad de Innovación Clínica y Epidemiológica del Estado de Guerrero, Secretaría de Salud Guerrero, Acapulco, México.